Activation of Apoptosis and Autophagy by Gratiola Officinalis Extract in Human Tumor Cell Lines by Polukonova, Natal’ya V., Baryshnikova, Maria A., Khochankov, Dmitry A., Stepanova, Evgeniya V., Solomko, Eliso S., Polukonova, Anna V., Mudrak, Dmitrij A., Mylnikov, Artem M., Bucharskaya, Alla B., Maslyakova, Galina N., Navolokin, Nikita A.

Get full text

Targeting FGFR2 with alofanib (RPT835) shows potent activity in tumour models by Tsimafeyeu, Ilya, Ludes-Meyers, John, Stepanova, Evgenia, Daeyaert, Frits, Kochenkov, Dmitry, Joose, Jean-Baptiste, Solomko, Eliso, Van Akene, Koen, Peretolchina, Nina, Yin, Wei, Ryabaya, Oxana, Byakhov, Mikhail, Tjulandin, Sergei

Get full text

Immunochemical expression of fibroblast growth factor and its receptors in primary tumor cells of renal cell carcinoma by Volkova, Maria, Tsimafeyeu, Ilya, Olshanskaya, Anna, Khochenkova, Yulia, Solomko, Eliso, Ashuba, Saida, Matveev, Vsevolod, Khochenkov, Dmitry

Get full text

Alofanib, an allosteric FGFR2 inhibitor, has potent effects on ovarian cancer growth in preclinical studies by Tyulyandina, Alexandra, Harrison, Daniel, Yin, Wei, Stepanova, Evgenia, Kochenkov, Dmitry, Solomko, Eliso, Peretolchina, Nina, Daeyaert, Frits, Joos, Jean-Baptiste, Van Aken, Koen, Byakhov, Mikhail, Gavrilova, Evgenia, Tjulandin, Sergei, Tsimafeyeu, Ilya

Get full text

Abstract 1737: Allosteric FGFR2 inhibitor RPT835 impacts on tumor growth and neovascularization by Tsimafeyeu, Ilya, Stepanova, Evgenia, Solomko, Eliso, Kochenkov, Dmitry, Peretolchina, Nina, Ryabaya, Oxana, Byakhov, Mikhail, Tjulandin, Sergey

Get full text

Corrigendum to ‘Targeting FGFR2 with alofanib (RPT835) shows potent activity in tumour models’ [Eur J Cancer 61 (2016) 20–28] by Tsimafeyeu, Ilya, Ludes-Meyers, John, Stepanova, Evgenia, Daeyaert, Frits, Khochenkov, Dmitry, Joose, Jean-Baptiste, Solomko, Eliso, Van Akene, Koen, Peretolchina, Nina, Yin, Wei, Ryabaya, Oxana, Byakhov, Mikhail, Tjulandin, Sergei

Get full text